U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07943143) titled 'Histotripsy for Renal Cell Carcinoma' on Sept. 17.
Brief Summary: The project will be a pilot study in localised or metastatic renal cell carcinoma, assessing safety, local control, and exploratory immune endpoints. Outcomes from this work will inform rational combinations with targeted agents and immune checkpoint blockade and may define a new, image-guided, non-invasive modality for renal cell carcinoma. If successful, histotripsy could become a new non-thermal, local therapy for renal cell carcinoma with dual benefits of debulking and immune activation achieving strong clinical and scientific impact.
Study Start Date: Oct. 13
S...